期刊文献+

以护理为主导的慢病管理对强直性脊柱炎患者治疗效果的影响 被引量:5

原文传递
导出
摘要 目的研究以护理为主导的慢病管理对强直性脊柱炎(AS)患者治疗效果的影响。方法选择该院风湿免疫科于2016年3~5月的35例AS患者为对照组,2017年3~5月收治的31例AS患者为观察组,对照组给予常规护理;观察组给予以护理为主导的慢病管理,比较两组患者12周后的治疗结果。结果观察组患者治疗效果显著优于对照组(P<0.05)。结论对强直性脊柱炎患者实施以护理为主导的慢病管理能够有效改善12周治疗效果,值得在临床中借鉴。
作者 姜珊 南鹤
出处 《国际护理学杂志》 2018年第23期3213-3215,共3页 international journal of nursing
  • 相关文献

参考文献2

二级参考文献12

  • 1Bertsias G,Ioannidis JP,Boletis J,et al.EULAR recommendations for the management of systemic lupus erythematosus.Report of a task force of the EULAR standing committee for international clinical studies including therapeutics[J].Ann Rheum Dis,2008,67(2):195-205.
  • 2Bertsias GK,Ioannidis JP,Aringer M,et al.EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations:report of a task force of the EULAR standing committee for clinical affairs[J].Ann Rheum Dis,2010,69(12):2074-2082.
  • 3Lee YH,Woo J-H,Choi SJ,et al.Induction and maintenance therapy for lupus nephritis:a systematic review and meta-analysis[J].Lupus,2010,19(6):703-710.
  • 4Kowal-Bielecka O,Landewé R,Avouac J,et al.EULAR recommendations for the treatment of systemic sclerosis:a report from the EULAR Scleroderma Trials and Research group (EUSTAR)[J].Ann Rheum Dis,2009,68(5):620-628.
  • 5Furst DE,Keystone EC,Braun J,et al.Updated consensus statement on biological agents for the treatment of rheumatic diseases,2010[J].Ann Rheum Dis,2011,70Suppl 1:i2-i36.
  • 6Health Technology Assessment Section.Medical Development Division.Ministry of Health Malaysia.Clinical practice guidelines.Management of gout[EB/OL].2008.http://www.moh.gov.my/v/rhe.
  • 7Jordan KM,Cameron JS,Snarth M,et al.British Society for Bheumatology and British health professionals in rheumatology guideline for the management of gout[J].Rheumatology(Oxford),2007,46(8):.1372-1374.
  • 8Luqmani R,Hennell S,Estrach C,et al.British society for rheumatology and British health professionals in rheumatology guideline for the management of rheumatoid arthritis (the first two years)[J].Rheumatology (Oxford),2006,45(9):1167-1169.
  • 9Saag KG,Teng GG,Patkar NM,et al.American college of rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis[J].Arthritis Rheum,2008,59(6):762-784.
  • 10Smolen JS,Landew(e) R,Breedveld FC,et al.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs[J].Ann Rheum Dis,2010,69(6):964-975.

共引文献39

同被引文献51

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部